Cidara Therapeutics to Participate in the World Antiviral Congress 2022

Posted: November 24, 2022 at 12:18 am

SAN DIEGO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that Jeff Stein, Ph.D., President and CEO, will participate in a panel discussion at the World Antiviral Congress being held in San Diego, California from November 28-December 1, 2022.

Read the rest here:
Cidara Therapeutics to Participate in the World Antiviral Congress 2022

Related Posts